Jonathan Trent
Associate Director, Clinical Research, Sylvester Comprehensive Cancer Center · University of Miami/Jackson Health System
Credentials: · · · · · ·
History
- Present
Musculoskeletal Center · University of Miami/Jackson Health System
- Present
Sarcoma Medical Research Program · University of Miami/Jackson Health System
- 1998–2000
Medical Oncology
Research
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
Journal of the National Comprehensive Cancer Network · 2010 · 908 citations
The Lancet Oncology · 2019 · Last of 15 authors · 331 citations
JAMA Oncology · 2016 · 311 citations
- RB
29 papers
28 papers · 3 as a fellow
27 papers
24 papers
23 papers
21 papers
21 papers
20 papers
Grants
- 2019–2029
The Sylvester Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $2.5M · University of Miami School of Medicine
- 2026–2027
- 2004–2010
Activity & Resistance of Gleevec in GI Stromal Tumors
National Cancer Institute · K23
Contact PI · $680.4K · University of Tx Md Anderson Can Ctr
- 2005–2009
3 D Electron Microscopy of Macromolecules
National Center for Research Resources · P41
Project lead · $49.3K · Baylor College of Medicine
Clinical trials
- 2023–2028
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
Principal investigator · Recruiting · Phase 2
University of Miami
- 2016–2023
Principal investigator · Completed · Phase 2
Jonathan Trent, MD, PhD
- 2005
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
- 2003–2011
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center